Jibeier Pharmaceutical: Application for the listing of the chemical raw material drug Gatifloxacin has been approved

Zhitong
2025.10.23 08:13

On October 23rd, Jibeier announced that the company recently received the "Approval Notice for the Application for the Listing of Chemical Raw Materials" issued by the National Medical Products Administration. The name of the chemical raw material is Gatifloxacin, which is the main ingredient of the company's Gatifloxacin eye drops. Gatifloxacin eye drops are mainly used for acute bacterial conjunctivitis caused by sensitive bacteria

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.